Posts

Invivyd receives FDA IND clearance for VYD222 to preven...

VYD222 is being assessed in an ongoing Phase I healthy volunteer clinical trial ...

Click Therapeutics kicks off digital therapy remote tri...

The Phase III trial taps into a growing trend of digital therapeutics use in neu...

Atea secures Fast Track designation for Covid-19 drug b...

Despite past challenges, the oral drug is now being studied in a global Phase II...

Singapore startup Albatroz wins financing to develop so...

As Singapore’s pharmaceutical industry gains investment, Albatroz completes fina...

Vedanta Biosciences raises funds to advance defined bac...

Vedanta plans to use the proceeds to support a pivotal Phase III trial of VE303 ...

US FDA grants orphan drug status to IN8bio’s INB-400 an...

INB-400 will be evaluated in a Phase II clinical trial in newly diagnosed gliobl...

MiNA and BioMarin partner to speed development of RNAa ...

The agreement will see MiNA receive an upfront payment and future royalties if B...

STAT+: Medicare official insists drug price negotiation...

When Medicare starts negotiating drug prices, it will take into account how impo...

Telehealth companies that provide abortion pills grappl...

In the latest edition of STAT's Health Tech newsletter: bad news for Oracle, tel...

STAT+: FDA approves new treatment from Biogen for rare ...

The FDA has granted conditional approval to a new treatment for a rare, genetic ...

STAT+: Sens. Bernie Sanders, Bill Cassidy reach deal on...

Sens. Bernie Sanders and Bill Cassidy laid out a bipartisan proposal to increase...

With little FDA oversight, melatonin supplements vary w...

A study found melatonin gummies that were three times more powerful than adverti...

STAT+: Pharmalittle: Novartis boosts its sales and prof...

Novartis raised its full-year sales and profit projections thanks to a crop of n...

STAT+: Morphic study shows promise — and blockbuster po...

An experimental oral medicine to treat ulcerative colitis showed promise — and b...

‘There’s a huge fatphobia problem in the eating disorde...

Eating disorder specialists disagree about how to best address obesity and weigh...

Opinion: Why involuntary treatment for addiction is a d...

Involuntary treatment might be worth it if it worked — but evidence strongly sug...